Keyword: cell and gene therapy
US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for...
Solvias, a Swiss CDMO serving the pharmaceutical, biotechnology, material science and cosmetic industries, has acquired Dutch biotech Cergentis for an undisclosed sum...
Markets & Companies
Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...
Leading US gene therapy CDMO Catalent is buying all shares of another CDMO in the same field, plasmid DNA (pDNA) specialist’s Delphi Genetics, headquartered at Gosselie...
- Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...